TraceLink expands offering with ROC IT Solutions acquisition
Company can now offer solutions for serialized receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products.
TraceLink has acquired ROC IT Solutions, the leader in intelligent edge data capture for serialized product inventory in the pharmaceutical supply chain.
The acquisition positions TraceLink as the only end-to-end platform that enables life sciences companies to capture, process and exchange serialized product data across a digital supply chain network, while also more effectively managing warehouse product inventory at the “edge” of the supply chain.
By acquiring ROC IT and integrating EdgeTRAC into its family of serialization software, TraceLink now offers solutions for serialized receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products. The acquisition also increases TraceLink’s physical presence in the US, bringing the total number of locations to two, including its global headquarters in North Reading, MA and a new office in Pittsford, NY.
“We are pleased to welcome ROC IT’s founding members, employees and valued customers to TraceLink. As industry pioneers and market leaders, both TraceLink and ROC IT have been working together since the early days of pharmaceutical track and trace, establishing an undeniable synergy with our respective technical expertise, industry knowledge and company cultures,” said Shabbir Dahod, president & CEO, TraceLink.
“This acquisition further widens our leadership position by seamlessly merging best-of-breed serialization capabilities into a comprehensive solution set that no other provider can offer. As a result, we’ll be able to serve broader serialization challenges in the pharmaceutical industry as well as explore new capabilities for real-time information sharing that support the longer-term business and patient safety goals of our customers.”
Larry Hall, co-founder and Vice President of Sales and Operations of ROC IT, added, “By joining forces with TraceLink, we have aligned ourselves with the winning team to build an even stronger collaboration to propel the industry forward. We look forward to this next chapter with TraceLink and ensuring the ongoing success of our customers, partners and team by leveraging TraceLink’s industry expertise, proven solutions and global customer success."
The specific warehouse operations capabilities now offered by TraceLink as a result of the ROC IT acquisition include
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.